Overview

Study of Intravaginal Tamoxifen in PostMenopausal Women With VVA

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to study the safety, PK and PD of Intravaginal Tamoxifen on postmenopausal women with vulvar vaginal atrophy.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Daré Bioscience, Inc.
Treatments:
Tamoxifen